Mercado Global de Gelatina Farmacêutica – Tendências da Indústria e Previsão para 2030

Análise e dimensão do mercado de gelatina farmacêutica

A crescente aplicação da gelatina em aplicações cosméticas, atividades intrínsecas e aplicações biomédicas em pensos e cicatrização de feridas , engenharia de tecidos, terapia genética , implantes e substitutos ósseos está a impulsionar o crescimento do mercado. O aumento da procura de gelatina em aplicações de alimentos funcionais devido à sua capacidade de prevenir diversas doenças, melhorar a qualidade dos alimentos e proteger os alimentos, foi concebido para alimentar o crescimento do mercado.

A Data Bridge Market Research analisa uma taxa de crescimento no mercado de gelatina farmacêutica no período de previsão 2023-2030. O CAGR esperado do mercado da gelatina farmacêutica tende a rondar os 5,7% no período de previsão mencionado. O mercado foi avaliado em 1,26 mil milhões de dólares em 2022 e cresceria até 1,97 mil milhões de dólares até 2030. Além dos insights de mercado, como o valor de mercado, taxa de crescimento, segmentos de mercado, cobertura geográfica, participantes no mercado e cenário de mercado, o O relatório de mercado com curadoria da equipa de pesquisa de mercado da Data Bridge inclui também uma análise especializada aprofundada, epidemiologia dos doentes, análise de pipeline, análise de preços e estrutura regulamentar.

Âmbito e segmentação do mercado de gelatina farmacêutica

Definição de mercado

Gelatin is a raw material that is used in the pharmaceutical industry. Gelatin capsules protects ingredients such as fish oil from oxygen, light, contamination or microbial growth. It is an essential factor that is used for the production of hard and soft capsules as well as film-coated and effervescence tablets. Around, 90% of all the pharmaceutical gelatin produced is processed into widely used drug dosage form.

Pharmaceutical Gelatin Market Dynamics

Drivers

• Increasing Demand of Choosing Healthy Lifestyle

The in-home consumption of convenience meals increased to 26% during the pandemic. Understanding the importance of health as a lifestyle choice has stimulated consumers in the F&B sector. Though, in the above forecast period, the personal care category is the market's fastest-growing segment, with a CAGR of 5.51%, by value because of higher average protein content of 5% in pharmaceutical gelatin compared to other dairy proteins like whey & milk proteins.

• Preference of Collagen Consumption

Most consumers prefer collagen consumption through their diet instead of taking it through injections, that is likely to produce higher product penetration in the food and beverage industry. For instance, numerous manufacturers, namely JBS and JIANGXI COSEN BIOLOGY CO., LTD. produce bovine grade collagen for food and beverage applications. Increasing demand for the mentioned products in confectionery and desserts is expected to boost the market growth.

Opportunities

• Increasing Technological Development

The increase in initiatives from the major market players to manufacture innovative gelatin capsules shells with innovative technologies is creating much opportunities for the market bgrowth. For instance, etectRx, Inc., which is a digital health startup, launched the beginning of a study to track antiretroviral therapy adherence among prescription opioid users who are surviving with human immuno virus (HIV). The "MyTPill" trial will assess patient adherence using the ID-Cap System which involves a hard gelatin capsule with an embedded ingestible wireless sensor and a wearable reader. Such great initiatives will lead to increased adoption of gelatin for the production of hard gelatin capsules (ID-Cap) boosting the market growth.

• Increase in Launch of New Products

The increase in the launch of new gelatin brands is also projected to drive the market growth in this region. For instance, in May 2021, GelDAT was launched by Darling Ingredients' Rousselot Brand. It launched X-Pure - GelDAT as an alternative for GelTYR - Gelatin Tyramine by considering the limitations, irreproducibility, and lack of a scalable production process of GelTYR. Such launch of innovative products will further boost the market growth because of the rise in adoption to their improved properties. Thus, all these factors are creating much opportunities for the market growth.

Restraints/Challenges

• Lack of skilled professionals

The lack of qualified healthcare professionals who are unable to use these devices could limit the growth of the global pharmaceutical gelatin market over a forecast period.

• High Cost of Gelatins

The huge expenditure that is associated with the gelatins are majorly impacting the growth of the market.  Prices have increased recently as there is huge concern that the higher feed prices seen because of the recent drought in Russia and the U.S. may be leading to a decline in the number of the animals from which gelatin is produced.

This pharmaceutical gelatin market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pharmaceutical gelatin market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Pharmaceutical Gelatin Market

COVID-19 has a great impact on the gelatin production and the supply chain. Lonza, which is a key player in the capsules segment, has stated that COVID-19 has impacted the demand and supply chain of pharmaceutical capsules. Whereas, gelatin also has found its importance in the COVID-19 treatment. For instance, as per the study titled 'Gelatin Stabilizes Nebulized Proteins in Pulmonary Drug Delivery against COVID-19' in May 2022, the addition of gelatin to the drug delivery considerably stabilizes the proteins and enhances the fractions of active proteins after nebulization, diminishing the medication dosage. Such many advantages of gelatin in COVID-19 patient's treatment will lead to higher adoption of pharmaceutical gelatin

Recent Developments

• In 2022, Lonza expanded its Capsugel offering with a titanium dioxide-free (TiO2-free) white hard gelatin capsule, meeting the demand of the food industry to meet requirements for foods in the European Union.

Global Pharmaceutical Gelatin Market Scope

The pharmaceutical gelatin market is segmented on the basis of type, treatment, source, route of administration, end-users, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Source

• Porcine
• Bovine Skin
• Bovine Bone
• Fish
• Poultry  

Function

• Stabilizing
•  Thickening
• Gelling  

End-Users

• Hard Capsule
• Soft Capsule
• Tablet
• Absorbable Hemostat

Pharmaceutical Gelatin Market Regional Analysis/Insights

O mercado da gelatina farmacêutica é analisado e os insights e tendências do tamanho do mercado são fornecidos por tipo, tratamento, fonte, via de administração, utilizadores finais, canal de distribuição como mencionado acima.

Os principais países abrangidos no relatório de mercado da gelatina farmacêutica  são os EUA, Canadá e México na América do Norte, Alemanha, França, Reino Unido, Holanda, Suíça, Bélgica, Rússia, Itália, Espanha, Turquia, Resto da Europa na Europa, China, Japão , Índia, Coreia do Sul, Singapura, Malásia, Austrália, Tailândia, Indonésia, Filipinas, Resto da Ásia-Pacífico (APAC) na Ásia-Pacífico (APAC), Arábia Saudita, Emirados Árabes Unidos, África do Sul, Egito , Israel, Resto do Médio Leste e África (MEA) como parte do Médio Oriente e África (MEA), Brasil, Argentina e Resto da América do Sul como parte da América do Sul.

A América do Norte domina o mercado da gelatina farmacêutica devido à presença de vários fabricantes importantes de gelatina produzida na indústria farmacêutica em termos de volume.

A Ásia-Pacífico é considerada como tendo o crescimento mais rentável devido aos menores custos de mão-de-obra e de capital para o fabrico de gelatina farmacêutica e ao aumento da frequência de osteoartrite e distúrbios de obesidade em todo o mundo.

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Além disso, são considerados a presença e disponibilidade de marcas globais e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas nacionais e das rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.   

Cenário competitivo e análise global da quota de mercado da gelatina farmacêutica

O panorama competitivo do mercado da gelatina farmacêutica fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado da gelatina farmacêutica

Os principais players que trabalham no mercado da gelatina farmacêutica incluem:

• Gelita AG (Alemanha)
• Trobas Pharmaceutical gelatine BV (Holanda)
• Rousselot (EUA)
• Weishardt (França)
• Gelatina Esterlina (Índia)
• Catalent, Inc (EUA)
• Nitta Pharmaceutical gelatin India Limited (Índia)
• Aspire Pharmaceuticals (EUA)
• Gelatinas Junca (Espanha)
• Gelco Internacional (Brasil)
• Norland Products Inc (EUA)
• Lapi Gelatina Spa (Itália)
• Trobus Gelatina BV (Holanda)

SKU-58567